The Use of Virtual Reality for the Treatment of Visual Vertigo.

NCT ID: NCT03020654

Last Updated: 2018-04-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

18 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study investigates the use of virtual environments presented on a head mounted display for the rehabilitation of those suffering with visual vertigo.

The control group and treatment groups will be presented with two different sets of environments and be given the same head and eye exercises to complete within the environment. They will also be provided with at home exercises to complete.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Visual vertigo occurs after the balance system suffers damage (e.g after a viral infection such as labyrinthitis). This causes an over-reliance on the eyes to maintain balance which causes disorientation in busy environments such as the supermarket. The treatment involves trying to desensitise the individual to visually stimulating situations. Further head and eye exercises are completed alongside the exposure to overcome the damage done to the balance system.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Treatment of Visual Vertigo

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Treatment group

Virtual environment with fast moving objects these are graded in intensity from 1-7. Participants complete head and eye exercises within the environment using focus points such as benches and lanterns for a six week treatment program.

Group Type EXPERIMENTAL

Virtual environment with fast moving objects

Intervention Type OTHER

A beach/park environment with graded moving objects, the individual will complete head and eye exercises.

Control group

Virtual environment with no movement graded at grade 0. Participants complete head and eye exercises within the environment using focus points such as benches and lanterns for a six week treatment program.

Group Type ACTIVE_COMPARATOR

Virtual environment with no movement

Intervention Type OTHER

A beach/park environment with static objects, the individual will complete head and eye exercises.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Virtual environment with fast moving objects

A beach/park environment with graded moving objects, the individual will complete head and eye exercises.

Intervention Type OTHER

Virtual environment with no movement

A beach/park environment with static objects, the individual will complete head and eye exercises.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Those who have been diagnosed with visual vertigo and have scored a significant level on the Situational Characteristic Questionnaire (over 0.74 as per Pavlou et al., 2006).

Exclusion Criteria

* Those with or under investigation for epilepsy.
* Those who have been determined to have no or limited balance function in both ears.
* Those with reduced visual acuity that will leave them unable to view the 3D effects of the head mounted display.
* Those with severe mental health disorders e.g. psychosis, paranoid disorders, bipolar disorder or a history of substance abuse.
* Severe neck pain/ restricted movement.
* Previous treatment for visual vertigo.
* Those with an fluctuating vestibular disorder such as Ménière's disease or vestibular migraine.
* Those with untreated Benign Paroxymal Positional Vertigo (BPPV).
* Those with a significant brain injury, or head injury that results in a central vestibular disorder.
* Those with an arrhythmia.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Manchester

OTHER

Sponsor Role collaborator

Sheffield Teaching Hospitals NHS Foundation Trust

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Kirsty M Walker, BSc

Role: PRINCIPAL_INVESTIGATOR

Sheffield Teaching Hospitals NHS Foundation Trust

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Royal Hallamshire Hospital

Sheffield, South Yorkshire, United Kingdom

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United Kingdom

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Kirsty M Walker, BSc

Role: CONTACT

011427112131

Paul Bacon, PhD

Role: CONTACT

01142712145

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Kirsty M Walker, BSc

Role: primary

01142712131

Paul Bacon, PhD

Role: backup

01142712145

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

5375

Identifier Type: OTHER

Identifier Source: secondary_id

STH19451

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Web-based Rehab After Acute Vertigo
NCT05056324 COMPLETED NA